TACE was performed according to our institutional standard protocol and has been previously reported (30 (link), 31 (link)). All operators had at least eight years of experience in performing TACE procedures. TACE was performed using transfemoral arterial access route with a micro-puncture system by placing a 5F vascular introducer (Cook, Bloomington, Indiana, USA) and celiac or superior mesenteric arteriography was carried out to assess the arterial anatomy, tumor supplying vessel and patency of the portal vein. A 2.6-Fr microcatheter (Terumo, Japan) was inserted into the tumor donor arteries as superselectively as possible to identify the staining and arteries feeding the target lesions. First, an emulsion of 5-20 mL lipiodol (Lipiodol Ultrafluido, Guerbet, France) mixed with 20-60 mg doxorubicin hydrochloride (Hisun Pharmaceutical Co. Ltd., Zhejiang, China) was injected into tumor feeding branch of the hepatic artery. Then the gelatin sponge particles (300–500 um, Cook, Bloomington, Indiana, USA) mixed with contrast material were administered into the tumor-feeding arteries until stasis of the arterial flow was achieved.
Free full text: Click here